Company intelligence / Profile preview

ExoStat Medical

Prior Lake, Minnesota, United Statesexostatmedical.com ↗

Ownership: Private
Development stage: Commercial

Overview

The MicroTREND System by ExoStat Medical received FDA 510(k) clearance in November 2024. It provides real-time, non-invasive monitoring of tissue hypoperfusion at the microcirculatory level using a disposable oral mucosal sensor to measure pCO2. Clinical research and development began in the late 1990s and continued through collaboration with leading critical care experts. The system aims to enable earlier detection and intervention for life-threatening shock states.

Therapeutic areas: Cardiovascular
Modalities: DeviceDiagnostic device (non-invasive sensor system)
Industry: Physiological Monitoring

Partnerships

Weil Institute of Critical Care Medicine (R&D collaboration)

Beyond the preview

Go deeper on ExoStat Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ExoStat Medical.

Explore the full profile